DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Rifalazil
Rifalazil
Rifalazil | Medchemexpress
EMA/CVMP/158366/2019 Committee for Medicinal Products for Veterinary Use
Anew Drug Design Strategy in the Liht of Molecular Hybridization Concept
Pharmaceutical Appendix to the Tariff Schedule 2
(12) United States Patent (10) Patent No.: US 8,097,607 B2 Cabana Et Al
Pharmacokinetic Drug Interactions of Antimicrobial Drugs: a Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams
Antibiotics Targets, Mechanisms and Resistance 1St
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
The Current Anti-TB Drug Research and Development Pipeline
539 A2062 516 A83016F 445 Acidic Phospholipids 187
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
(12) Patent Application Publication (10) Pub. No.: US 2007/0248668A1 Michaelis Et Al
WO 2017/059411 Al 6 April 2017 (06.04.2017) W P O P C T
Identification of Whole Cell Active Molecules of Mycobacterium Tuberculosis, Elucidation of Molecular Mechanisms Responsible
Pharmaabkommen A1 E
Handbook of Anti-Tuberculosis Agents
Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria
Top View
Pharmaceutical Composition and Kit for Treating Bacterial Infections
Infectious Diseases, 3D Edition Elsevier/Mosby, 2010 Available on Line At
Rifalazil and Derivative Compounds Show Potent Efficacy in a Mouse
1 a Chemist's Survey of Different Antibiotic Classes
Drug Resistance Mechanisms in Mycobacterium Tuberculosis
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
Survey of Drug Resistance Associated Gene Mutations in Mycobacterium Tuberculosis, ESKAPE and Other Bacterial Species Abhirupa Ghosh1,2, Saran N.1,2 & Sudipto Saha1 ✉
Course on Multidrug-Resistant Tuberculosis MDR-TB COURSE on MULTIDRUG-RESISTANT TUBERCULOSIS MDR-TB
Wo 2008/021089 A2
(12) Patent Application Publication (10) Pub. No.: US 2010/0016333 A1 Flanner Et Al
An Overview on Antitubercular Activities of Fluoroquinolones and Other Related Analogues
Controversy About the Role of Rifampin in Biofilm Infections
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Short Treatment for Tuberculosis
Harmonized Tariff Schedule of the United States (2006) (Rev
That Are Not Communitie
In Vitro Time-Kill Activities of Rifalazil, Alone and in Combination with Vancomycin, Against Logarithmic and Stationary Cultures of Staphylococcus Aureus Marcia S
Priftin® (Rifapentine) 150 Mg Tablets
Schedule Clxxiii - European Union
Rifalazil Retains Activity Against Rifampin-Resistant Mutants of Chlamydia Pneumoniae David M